Showing 1 - 13 results of 13 for search 'Tony R Reid', query time: 0.04s Refine Results
  1. 1
    Commentary on oncolytic viruses: past, present, and future

    Commentary on oncolytic viruses: past, present, and future by Christopher Larson, Bryan Oronsky, Tony R Reid

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply

    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply by Bryan Oronsky, Christopher Larson, Scott Caroen, Tony R. Reid

    Published 2022-12-01
    Get full text
    Article
  3. 3
    What's New in SCLC? A Review

    What's New in SCLC? A Review by Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Corey A. Carter

    Published 2017-10-01
    Get full text
    Article
  4. 4
    A Review of Newly Diagnosed Glioblastoma

    A Review of Newly Diagnosed Glioblastoma by Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Navjot Sandhu, Susan J. Knox

    Published 2021-02-01
    Get full text
    Article
  5. 5
    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic" by Bryan Oronsky, Corey A. Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky, Tony R. Reid

    Published 2020-01-01
    Get full text
    Article
  6. 6
    Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer

    Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer by Bryan Oronsky MD, Chris Larson MD, PhD, Tony R. Reid MD, PhD, Corey A. Carter MD

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets

    Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets by Corey A. Carter, Bryan Oronsky, Scott Caroen, Jan Scicinski, Aiste Degesys, Pedro Cabrales, Tony R. Reid, Christina Brzezniak

    Published 2016-05-01
    Get full text
    Article
  8. 8
    A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)

    A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs) by Christopher Larson, Bryan Oronsky, Gina Varner, Scott Caroen, Erica Burbano, Elisa Insel, Farah Hedjran, Corey A. Carter, Tony R. Reid

    Published 2018-09-01
    Get full text
    Article
  9. 9
    Data Management 101 for drug developers: A peek behind the curtain

    Data Management 101 for drug developers: A peek behind the curtain by Bryan Oronsky, Erica Burbano, Meaghan Stirn, Joanne Brechlin, Nacer Abrouk, Scott Caroen, Angelique Coyle, Jeannie Williams, Pedro Cabrales, Tony R. Reid

    Published 2023-09-01
    Get full text
    Article
  10. 10
    Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance

    Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance by Bryan Oronsky, Corey A. Carter, Tony R. Reid, Jan Scicinski, Arnold Oronsky, Michelle Lybeck, Scott Caroen, Meaghan Stirn, Neil Oronsky, Peter Langecker

    Published 2015-09-01
    Get full text
    Article
  11. 11
    Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

    Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001 by Corey A. Carter, Bruno Schmitz, P. Gabriel Peterson, Mary Quinn, Aiste Degesys, John Jenkins, Bryan Oronsky, Jan Scicinski, Scott Caroen, Tony R. Reid, Pedro Cabrales, Christina Brzezniak

    Published 2016-03-01
    Get full text
    Article
  12. 12
    Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

    Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents by Bryan Oronsky, Jan Scicinski, Michelle M. Kim, Pedro Cabrales, Michael E. Salacz, Corey A. Carter, Neil Oronsky, Harry Lybeck, Michelle Lybeck, Christopher Larson, Tony R. Reid, Arnold Oronsky

    Published 2016-07-01
    Get full text
    Article
  13. 13
    RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor

    RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor by Christina Brzezniak, Bryan Oronsky, Jane Trepel, Thomas A. Summers Jr., Pedro Cabrales, Min-Jung Lee, Regina Day, Saheli Jha, Scott Caroen, Karen Zeman, Lindsey Ferry, Cindy Harmer, Neil Oronsky, Michelle Lybeck, Harry E. Lybeck, James F. Brown, Tony R. Reid, Corey A. Carter

    Published 2017-03-01
    Get full text
    Article

Search Tools: